John McKew

John McKew

Präsident bei LUMOS PHARMA, INC.

Vermögen: 47 342 $ am 30.04.2024

59 Jahre
Health Technology
Consumer Services
Government

Ursprung des Netzwerks ersten Grades von John McKew

EinheitArt der EinheitIndustrie
Public Company Pharmaceuticals: Major 21
Public Company Pharmaceuticals: Major 10
9
Government General Government 9
Boston University School of Medicine
5
College/University Other Consumer Services 5
2
Subsidiary Medical/Nursing Services 2

Unternehmensgrafik - zweiten Grades

Beziehungen zu mehreren Unternehmen

Unternehmensverbindungen über das persönliche Netzwerk von John McKew

UnternehmenSektorVerknüpfte PersonenHauptposition
Stanford University School of Medicine College/University

David Karpf

Emmett Cunningham

Thomas Raffin

Charles Link

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Doctorate Degree

Corporate Officer/Principal

Stanford University College/University

Srini Akkaraju Akkaraju

Edward Penhoet

Thomas Raffin

Jennifer F. Tseng

Doctorate Degree

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Miscellaneous Commercial Services

Gil Omenn

Edward Penhoet

Nancy Andrews

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of California San Diego College/University

David Karpf

Emmett Cunningham

David Weiner

Fred Ramsdell

Doctorate Degree

Doctorate Degree

Corporate Officer/Principal

Undergraduate Degree

SAVARA INC. Pharmaceuticals: Major

Richard Hawkins

Joseph McCracken

An van Es-Johansson

Director/Board Member

Director/Board Member

Director/Board Member

Biotechnology

Srini Akkaraju Akkaraju

Joseph McCracken

Ashraf Amanullah

Corporate Officer/Principal

Corporate Officer/Principal

Corporate Officer/Principal

University of Michigan College/University

Gil Omenn

Carole Nüchterlein

John Niederhuber

Chief Tech/Sci/R&D Officer

Graduate Degree

Corporate Officer/Principal

Miscellaneous Commercial Services

Gil Omenn

Edward Penhoet

Nancy Andrews

Corporate Officer/Principal

Corporate Officer/Principal

Chairman

Harvard Medical School College/University

Gil Omenn

Mark Goldberg

Nancy Andrews

Doctorate Degree

Doctorate Degree

Doctorate Degree

Biotechnology

Srini Akkaraju Akkaraju

Edward Penhoet

Emmett Cunningham

Director/Board Member

Director/Board Member

Corporate Officer/Principal

Miscellaneous Commercial Services

Nancy Andrews

John Niederhuber

Corporate Officer/Principal

Corporate Officer/Principal

CYMABAY THERAPEUTICS, INC. Biotechnology

Edward Penhoet

David Karpf

Chairman

Chief Tech/Sci/R&D Officer

The Johns Hopkins University College/University

Emmett Cunningham

Mahendra S. Rao

Doctorate Degree

Corporate Officer/Principal

University of California, Berkeley College/University

Edward Penhoet

David Karpf

Corporate Officer/Principal

Undergraduate Degree

Texas Tech University College/University

Lota Zoth

Aaron Schuchart

Undergraduate Degree

Undergraduate Degree

Harvard College College/University

Mark Goldberg

Gary Nabel

Undergraduate Degree

Undergraduate Degree

Medical Specialties

Kevin Lalande

Thomas Raffin

Director/Board Member

Director/Board Member

LDR HOLDING CORP Medical Specialties

Kevin Lalande

Thomas Raffin

Director/Board Member

Director/Board Member

GALERA THERAPEUTICS, INC. Pharmaceuticals: Major

Emmett Cunningham

Eugene Kennedy

Director/Board Member

Chief Tech/Sci/R&D Officer

College/University

Gary Nabel

Jennifer F. Tseng

Doctorate Degree

Graduate Degree

PLUS THERAPEUTICS, INC. Pharmaceuticals: Major

Richard Hawkins

An van Es-Johansson

Chairman

Director/Board Member

Drugstore Chains

Richard Hawkins

Robert J. Davis

Chief Executive Officer

Corporate Officer/Principal

College/University

Gil Omenn

Edward Penhoet

Corporate Officer/Principal

Doctorate Degree

Miscellaneous Commercial Services

Thomas Raffin

Charles Link

Director/Board Member

Director/Board Member

AMBIT BIOSCIENCES CORP Pharmaceuticals: Major

Carole Nüchterlein

Marcy Graham

Director/Board Member

Investor Relations Contact

University of Iowa College/University

Garry Neil

Carl W. Langren

Corporate Officer/Principal

Undergraduate Degree

Drake University Law School College/University

Chad Johnson

Bradley Powers

Graduate Degree

Graduate Degree

Biotechnology

Jon Saxe

Joseph McCracken

General Counsel

Corporate Officer/Principal

Medical Specialties

Frédéric Chéreau

Mark Goldberg

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Iowa State University College/University

Chad Johnson

Bradley Powers

Graduate Degree

Graduate Degree

Biotechnology

Charles Link

Carl W. Langren

Chairman

Director of Finance/CFO

New York University College/University

Emmett Cunningham

Martha Somerman

Corporate Officer/Principal

Undergraduate Degree

UCSF School of Medicine College/University

Emmett Cunningham

Jennifer F. Tseng

Corporate Officer/Principal

Doctorate Degree

Biotechnology

Yossef Av-Gay

Founder

Miscellaneous Commercial Services

Mahendra S. Rao

Founder

Miscellaneous Commercial Services

Mahendra S. Rao

Corporate Officer/Principal

University of Utah College/University

Mahendra S. Rao

Corporate Officer/Principal

College/University

Mahendra S. Rao

Doctorate Degree

University of Mumbai College/University

Mahendra S. Rao

Undergraduate Degree

Central Iowa Hospital Corp.

Charles Link

Founder

Pharmaceuticals: Major

Charles Link

Director/Board Member

THERMOGENESIS HOLDINGS, INC. Medical Specialties

Mahendra S. Rao

Director/Board Member

Pharmaceuticals: Major

Mahendra S. Rao

Founder

AADI BIOSCIENCE, INC. Biotechnology

Marcy Graham

Investor Relations Contact

Statistik

International

Vereinigte Staaten 47
Indien 3
Belgien 2
Israel 2

Sektoral

Health Technology 22
Consumer Services 20
Commercial Services 8
Retail Trade 2
Electronic Technology 2

Operativ

Director/Board Member 305
Corporate Officer/Principal 150
Independent Dir/Board Member 90
Chairman 50
Chief Tech/Sci/R&D Officer 48
  1. Börse
  2. Insiders
  3. John McKew
  4. Unternehmensverbindungen
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT